Article
Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma
1 Apr 2021
Abstract excerpt
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor, resulting a challenge of developing target therapeutics. Not long ago, immune checkpoint blockade regimens combine with tyrosin kinase inhibitors have evolved frontline options in metastatic RCC, which implies arrival of the era of tumor immunotherapy. Studies have demonstrated immune-related genes (IRGs) could characterize tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
